Investigation of the neuroprotective action of saffron (Crocus sativus L.) in aluminum-exposed adult mice through behavioral and neurobiochemical assessment

Food and Chemical Toxicology

Volumn 52, Issue , 2013, Pages 163-170

  Linardaki, Zacharoula I ^a   Orkoula, Malvina G ^a   Kokkosis, Alexandros G ^a   Lamari, Fotini N ^a   Margarity, Marigoula ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Aluminum; Cholinesterases; Memory; Monoamine oxidase; Oxidative stress; Saffron

Indexed keywords

ACETYLCHOLINESTERASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CHOLINESTERASE; CROCETIN; CROCUS SATIVUS EXTRACT; GLUTATHIONE; ISOENZYME; LIPID;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN LEVEL; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEARNING; LIPID PEROXIDATION; MALE; MEMORY; MEMORY DISORDER; MENTAL PERFORMANCE; MOUSE; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; TREATMENT DURATION;

ACETYLCHOLINESTERASE; ALUMINUM; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CAROTENOIDS; COGNITION; CROCUS; GLUTATHIONE; INJECTIONS, INTRAPERITONEAL; LEARNING; LIPID PEROXIDATION; LIVER; MALONDIALDEHYDE; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED BALB C; MONOAMINE OXIDASE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PLANT EXTRACTS;

EID: 84875121716     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.11.016     Document Type: Article

References (65)

1. Akhondzadeh S., Tahmacebi-Pour N., Noorbala A.A., Amini H., Fallah-Pour H., Jamshidi A.H., Khani M. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother. Res. 2005, 19:148-151.
2. Akhondzadeh S., Sabet M.S., Harirchian M.H., Togha M., Cheraghmakani H., Razeghi S., Hejazi S. Sh., Yousefi M.H., Alimardani R., Jamshidi A., Zare F., Moradi A. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial. J. Clin. Pharm. Ther. 2010, 35:581-588.
3. Bathaie S.Z., Mousavi S.Z. New applications and mechanisms of action of saffron and its important ingredients. Crit. Rev. Food Sci. Nutr. 2010, 50:761-786.
4. Bellés M., Sánchez D.J., Gómez M., Corbella J., Domingo J.L. Silicon reduces aluminum accumulation in rats: relevance to the aluminum hypothesis of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1998, 12:83-87.
5. Bhalla P., Dhawan D.K. Protective role of lithium in ameliorating the aluminium-induced oxidative stress and histological changes in rat brain. Cell. Mol. Neurobiol. 2009, 29:513-521.
6. Bhalla P., Garg M.L., Dhawan D.K. Protective role of lithium during aluminium-induced neurotoxicity. Neurochem. Int. 2010, 56:256-262.
7. Blaylock R.L. Aluminum induced immunoexcitotoxicity in neurodevelopmental and neurodegenerative disorders. Curr. Inorg. Chem. 2012, 2:46-53.
8. Bortolato M., Chen K., Shih J.C. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv. Drug Deliv. Rev. 2008, 60:1527-1533.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
10. Chryssanthi D.G., Lamari F.N., Georgakopoulos C.D., Cordopatis P. A new validated SPE-HPLC method for monitoring crocetin in human plasma-application after saffron tea consumption. J. Pharm. Biomed. Anal. 2011, 55:563-568.
11. Das A., Dikshit M., Nath C. Role of molecular isoforms of acetylcholinesterase in learning and memory functions. Pharmacol. Biochem. Behav. 2005, 81:89-99.
12. Dave K.R., Syal A.R., Katyare S.S. Effect of long-term aluminum feeding on kinetics attributes of tissue cholinesterases. Brain Res. Bull. 2002, 58:225-233.
13. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
14. El-Maraghy S.A., Gad M.Z., Fahim A.T., Hamdy M.A. Effect of cadmium and aluminum intake on the antioxidant status and lipid peroxidation in rat tissues. J. Biochem. Mol. Toxicol. 2001, 15:207-214.
15. Erasmus R.T., Savory J., Wills M.R., Herman M.M. Aluminum neurotoxicity in experimental animals. Ther. Drug Monit. 1993, 15:588-592.
16. Esparza J.L., Gómez M., Rosa Nogués M., Paternain J.L., Mallol J., Domingo J.L. Melatonin reduces oxidative stress and increases gene expression in the cerebral cortex and cerebellum of aluminum-exposed rats. J. Pineal Res. 2005, 39:129-136.
17. Fernández-Gómez F.J., Muñoz-Delgado E., Montenegro M.F., Campoy F.J., Vidal C.J., Jordán J. The level of butyrylcholinesterase activity increases and the content of the mRNA remains unaffected in brain of senescence-accelerated mouse SAMP8. Chem. Biol. Interact. 2008, 175:332-335.
18. Geromichalos G.D., Lamari F.N., Papandreou M.A., Trafalis D.T., Margarity M., Papageorgiou A., Sinakos Z. Saffron as a source of novel acetylcholinesterase inhibitors: molecular docking and in vitro enzymatic studies. J. Agric. Food Chem. 2012, 60:6131-6138.
19. Gulya K., Szikra J., Kása P. [D-Pen2, D-Pen5]enkephalin, a delta opioid agonist reduces endogenous aluminum content in the rat central nervous system. Neuroscience 1995, 66:499-506.
20. Hanish Singh J.C., Alagarsamy V., Sathesh Kumar S., Narsimha Reddy Y. Neurotransmitter metabolic enzymes and antioxidant status on Alzheimer's disease induced mice treated with Alpinia galanga (L.) Willd. Phytother. Res. 2011, 25:1061-1067.
21. Hosseinzadeh H., Sadeghnia H.R. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J. Pharm. Pharm. Sci. 2005, 8:394-399.
22. Huh J.W., Choi M.M., Lee J.H., Yang S.J., Kim M.J., Choi J., Lee K.H., Lee J.E., Cho S.W. Activation of monoamine oxidase isotypes by prolonged intake of aluminum in rat brain. J. Inorg. Biochem. 2005, 99:2088-2091.
23. Johnson K.E., Treble R.G. Determination of aluminum in biological fluids by furnace atomic absorption spectrophotometry. J. Clin. Lab. Anal. 1992, 6:264-268.
24. Julka D., Sandhir R., Gill K.D. Altered cholinergic metabolism in rat CNS following aluminum exposure: implications on learning performance. J. Neurochem. 1995, 65:2157-2164.
25. Jyoti A., Sharma D. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain. Neurotoxicology 2006, 27:451-457.
26. Kaizer R.R., Corrêa M.C., Gris L.R., da Rosa C.S., Bohrer D., Morsch V.M., Schetinger M.R. Effect of long-term exposure to aluminum on the acetylcholinesterase activity in the central nervous system and erythrocytes. Neurochem. Res. 2008, 33:2294-2301.
27. Kaneko N., Yasui H., Takada J., Suzuki K., Sakurai H. Orally administrated aluminum-maltolate complex enhances oxidative stress in the organs of mice. J. Inorg. Biochem. 2004, 98:2022-2031.
28. Kaneto H. Learning/memory processes under stress conditions. Behav. Brain Res. 1997, 83:71-74.
29. Kawahara M., Kato-Negishi M. Link between aluminum and the pathogenesis of Alzheimer's disease: the integration of the aluminum and amyloid cascade hypotheses. Int. J. Alzheimers Dis. 2011, 2011:276393.
30. Kumar S. Aluminium-induced changes in the rat brain serotonin system. Food Chem. Toxicol. 2002, 40:1875-1880.
31. Kumar V., Gill K.D. Aluminium neurotoxicity: neurobehavioural and oxidative aspects. Arch. Toxicol. 2009, 83:965-978.
32. Lane R.M., Potkin S.G., Enz A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int. J. Neuropsychopharmacol. 2006, 9:101-124.
33. Lassiter T.L., Barone S., Padilla S. Ontogenetic differences in the regional and cellular acetylcholinesterase and butyrylcholinesterase activity in the rat brain. Dev. Brain Res. 1998, 105:109-123.
34. Li B., Stribley J.A., Ticu A., Xie W., Schopfer L.M., Hammond P., Brimijoin S., Hinrichs S.H., Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 2000, 75:1320-1331.
35. Mahmood I., Neau S.H., Mason W.D. An enzymatic assay for the MAO-B inhibitor selegiline in plasma. J. Pharm. Biomed. Anal. 1994, 12:895-899.
36. Mallajosyula J.K., Kaur D., Chinta S.J., Rajagopalan S., Rane A., Nicholls D.G., Di Monte D.A., Macarthur H., Andersen J.K. MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology. PLoS One 2008, 3:e1616.
37. Melo A., Monteiro L., Lima R.M., Oliveira D.M., Cerqueira M.D., El-Bachá R.S. Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxid. Med. Cell. Longev. 2011, 2011:467180.
38. Missel J.R., Schetinger M.R., Gioda C.R., Bohrer D.N., Pacholski I.L., Zanatta N., Martins M.A., Bonacorso H., Morsch V.M. Chelating effect of novel pyrimidines in a model of aluminum intoxication. J. Inorg. Biochem. 2005, 99:1853-1857.
39. Mokrasch L.C., Teschke E.J. Glutathione content of cultured cells and rodent brain regions: a specific fluorometric assay. Anal. Biochem. 1984, 140:506-509.
40. Nehru B., Bhalla P. Reversal of an aluminium induced alteration in redox status in different regions of rat brain by administration of centrophenoxine. Mol. Cell. Biochem. 2006, 290:185-191.
41. Noorbala A.A., Akhondzadeh S., Tahmacebi-Pour N., Jamshidi A.H. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J. Ethnopharmacol. 2005, 97:281-284.
42. Ochiai T., Shimeno H., Mishima K., Iwasaki K., Fujiwara M., Tanaka H., Shoyama Y., Toda A., Eyanagi R., Soeda S. Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochim. Biophys. Acta 2007, 1770:578-584.
43. Otano A., García-Osta A., Ballaz S., Frechilla D., Del Río J. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors. Br. J. Pharmacol. 1999, 128:1691-1698.
44. Oteiza P.I. A mechanism for the stimulatory effect of aluminum on iron-induced lipid peroxidation. Arch. Biochem. Biophys. 1994, 308:374-379.
45. Papandreou M.A., Kanakis C.D., Polissiou M.G., Efthimiopoulos S., Cordopatis P., Margarity M., Lamari F.N. Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J. Agric. Food Chem. 2006, 54:8762-8768.
46. Papandreou M.A., Dimakopoulou A., Linardaki Z.I., Cordopatis P., Klimis-Zacas D., Margarity M., Lamari F.N. Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity. Behav. Brain Res. 2009, 198:352-358.
47. Papandreou M.A., Tsachaki M., Efthimiopoulos S., Cordopatis P., Lamari F.N., Margarity M. Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection. Behav. Brain Res. 2011, 219:197-204.
48. Pitsikas N., Sakellaridis N. Crocus sativus L. extracts antagonize memory impairments in different behavioural tasks in the rat. Behav. Brain Res. 2006, 173:112-115.
49. Platt B., Carpenter D.O., Büsselberg D., Reymann K.G., Riedel G. Aluminum impairs hippocampal long-term potentiation in rats in vitro and in vivo. Exp. Neurol. 1995, 134:73-86.
50. Sánchez-Iglesias S., Soto-Otero R., Iglesias-González J., Barciela-Alonso M.C., Bermejo-Barrera P., Méndez-Alvarez E. Analysis of brain regional distribution of aluminium in rats via oral and intraperitoneal administration. J. Trace Elem. Med Biol. 2007, 21(Suppl. 1):31-34.
51. Schmidt M., Betti G., Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien. Med. Wochenschr. 2007, 157:315-319.
52. Sethi P., Jyoti A., Singh R., Hussain E., Sharma D. Aluminium-induced electrophysiological, biochemical and cognitive modifications in the hippocampus of aging rats. Neurotoxicology 2008, 29:1069-1079.
53. + ATPase and protein kinase C in adult and old rat brain regions. Biogerontology 2009, 10:489-502.
54. Shati A.A., Elsaid F.G., Hafez E.E. Biochemical and molecular aspects of aluminium chloride-induced neurotoxicity in mice and the protective role of Crocus sativus L. extraction and honey syrup. Neuroscience 2011, 175:66-74.
55. Tarantilis P.A., Tsoupras G., Polissiou M. Determination of saffron (Crocus sativus L.) components in crude plant extract using high-performance liquid chromatography-UV-visible photodiode-array detection-mass spectrometry. J. Chromatogr. A 1995, 699:107-118.
56. Tomljenovic L. Aluminum and Alzheimer's disease: after a century of controversy, is there a plausible link?. J. Alzheimers Dis. 2011, 23:567-598.
57. Tripathi S., Mahdi A.A., Nawab A., Chander R., Hasan M., Siddiqui M.S., Mahdi F., Mitra K., Bajpai V.K. Influence of age on aluminum induced lipid peroxidation and neurolipofuscin in frontal cortex of rat brain: a behavioral, biochemical and ultrastructural study. Brain Res. 2009, 1253:107-116.
58. Verstraeten S.V., Aimo L., Oteiza P.I. Aluminium and lead: molecular mechanisms of brain toxicity. Arch. Toxicol. 2008, 82:789-802.
59. Walton J.R., Wang M.X. APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease. J. Inorg. Biochem. 2009, 103:1548-1554.
60. Xie C.X., Mattson M.P., Lovell M.A., Yokel R.A. Intraneuronal aluminum potentiates iron-induced oxidative stress in cultured rat hippocampal neurons. Brain Res. 1996, 743:271-277.
61. Xu Y., Wang Z., You W., Zhang X., Li S., Barish P.A., Vernon M.M., Du X., Li G., Pan J., Ogle W.O. Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system. Eur. Neuropsychopharmacol. 2010, 20:405-413.
62. Yokel R.A., Allen D.D., Ackley D.C. The distribution of aluminum into and out of the brain. J. Inorg. Biochem. 1999, 76:127-132.
63. Yokel R.A. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J. Alzheimers Dis. 2006, 10:223-253.
64. Yoshino F., Yoshida A., Umigai N., Kubo K., Lee M.C. Crocetin reduces the oxidative stress induced reactive oxygen species in the stroke-prone spontaneously hypertensive rats (SHRSPs) brain. J. Clin. Biochem. Nutr. 2011, 49:182-187.
65. Zhang Z.J., Qian Y.H., Hu H.T., Yang J., Yang G.D. The herbal medicine Dipsacus asper wall extract reduces the cognitive deficits and overexpression of beta-amyloid protein induced by aluminum exposure. Life Sci. 2003, 73:2443-2454.